Neurodegenerative diseases pose enormous challenges for societies and health- care systems. Two German biotech companies are taking different approaches, combining proprietary platforms with ...
Personalised cancer therapies have long been considered one of medicine’s most promising frontiers. Recent clinical results from Merck and Moderna involving mRNA-based approaches have added fresh ...
Every early-stage life sciences asset is heading towards the most regulated industry in the world. The process used to evaluate these as- sets, however, is rarely held to any comparable standard.
DEBRA Research has invested in Topadur Pharma to support the preclinical development of small-molecule therapies for ...
neoplas med GmbH from Greifswald, Germany, is considered a pioneer in medical cold plasma therapy. The company has been setting standards since its foundation in 2009. ‘We are revolutionising the ...
The fourth Edition of the Biotech Summit Austria brought together leading voices from research, industry, startups, investment and policy in Innsbruck this week. Jointly organized by Biotech Austria, ...
Telix Pharmaceuticals and ITM Isotope Technologies Munich are joining forces to create a leading radiopharmaceutical company. Telix has signed a strategic agreement to acquire 100% of the shares in ...
Germany was about to start. The legal foundation had been laid, and the relevant law was on its way to taking effect. – particularly in and regarding the life sciences.stock.adobe.com, bernardbodo ...
Gilead’s acquisition of Munich-based Tubulis earlier this year has put German antibody-drug conjugate (ADC) innovation into the global spotlight. With a total deal value of up to USD 5 billion, it was ...
ESMT Berlin und KfW Capital haben ein Leadership-Programm entwickelt, das Fondsmanager sowie Kapitalgeber auf ihre Aufgaben ...
Erfolgreiche Venture Capital-Investitionen erfordern mehr als Fachwissen: Führungskompetenz, strategischer Weitblick und belastbare Netzwerke sind entscheidend. Die ESMT Berlin und KfW Capital haben ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results